SCHEMBL7779710

SCHEMBL7779710

Cc1ccc(-c2cn(Cc3ccccc3)nc2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
PTGS2 P35354 6/20 0.55
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
DUSP3 P51452 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CA1 P00915 7/20 0.47
CA2 P00918 7/20 0.47
CA9 Q16790 7/20 0.47
CA12 O43570 6/20 0.47
CYP2C9 P11712 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
PTGS1 P23219 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780104 0.93 PTGS2 (0.55) RAB9ASMN1; SMN2NPC1PTGS2CA1
SCHEMBL7780480 0.89 PTGS2 (0.55) RAB9ASMN1; SMN2NPC1PTGS2CA1
SCHEMBL7780074 0.89 PTGS2 (0.64) RAB9ASMN1; SMN2NPC1PTGS2KMT2A
SCHEMBL7777584 0.88 PTGS2 (0.63) PTGS2KMT2ACA1CA2CA9
SCHEMBL7777871 0.88 PTGS2 (0.58) PTGS2KMT2AMEN1CA1CA2
SCHEMBL8631646 0.86 SMN1; SMN2 (0.54) RAB9ASMN1; SMN2NPC1PTGS2KMT2A
SCHEMBL7779558 0.85 PTGS2 (0.49) RAB9ASMN1; SMN2NPC1PTGS2KMT2A
SCHEMBL7780774 0.84 CA9 (0.50) PTGS2KMT2AMEN1CA1CA2
SCHEMBL7777498 0.83 PTGS2 (0.68) RAB9ASMN1; SMN2NPC1PTGS2LMNA
SCHEMBL7777312 0.82 CA9 (0.51) PTGS2KMT2ACA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed